165 related articles for article (PubMed ID: 38039741)
21. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the expression of microRNA-15a-5p and YAP1 gene in oral squamous cell carcinoma in comparison with normal tissue: A cross-sectional study.
Saravana Murthy P; Kannan A; Ganesan A; Lakshmi KC; Aniyan Kumbalaparambil Y
J Oral Pathol Med; 2023 Aug; 52(7):593-600. PubMed ID: 37285474
[TBL] [Abstract][Full Text] [Related]
23. THE STUDY OF PROGNOSTIC VALUE OF microRNAs (miR-10b AND -155) AND CDKN2A/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA.
Kravets О; Burtyn O; Borikun T; Rossylna O
Exp Oncol; 2023 Oct; 45(2):187-194. PubMed ID: 37824773
[TBL] [Abstract][Full Text] [Related]
24. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
Chen CM; Chu TH; Chou CC; Chien CY; Wang JS; Huang CC
Oral Oncol; 2021 Sep; 120():105402. PubMed ID: 34174519
[TBL] [Abstract][Full Text] [Related]
25. miR-196b-5p and miR-107 Expression Differentiates Ocular Sebaceous Carcinoma from Squamous Cell Carcinoma of the Conjunctiva.
de Keizer ROB; Vriends ALM; Hötte GJ; Paridaens DA; Wiemer EAC; Verdijk RM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563269
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts.
Álvarez-Teijeiro S; Menéndez ST; Villaronga MÁ; Rodrigo JP; Manterola L; de Villalaín L; de Vicente JC; Alonso-Durán L; Fernández MP; Lawrie CH; García-Pedrero JM
Sci Rep; 2017 Dec; 7(1):17785. PubMed ID: 29259267
[TBL] [Abstract][Full Text] [Related]
28. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
29. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
30. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
31. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
32. Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.
Sun C; Li J
J BUON; 2018; 23(1):167-172. PubMed ID: 29552778
[TBL] [Abstract][Full Text] [Related]
33. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma.
Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK
Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.
Maruyama T; Nishihara K; Umikawa M; Arasaki A; Nakasone T; Nimura F; Matayoshi A; Takei K; Nakachi S; Kariya KI; Yoshimi N
Oncol Lett; 2018 Feb; 15(2):2349-2363. PubMed ID: 29434944
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
37. A snapshot of miRNAs in oral squamous cell carcinoma: Difference between cancer cells and corresponding normal cells.
Hosseini V; Montazersaheb S; Hejazi N; Aslanabadi S; Mohammadinasr M; Hejazi MS
Pathol Res Pract; 2023 Sep; 249():154731. PubMed ID: 37573620
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.
Chang CC; Yang YJ; Li YJ; Chen ST; Lin BR; Wu TS; Lin SK; Kuo MY; Tan CT
Oral Oncol; 2013 Sep; 49(9):923-931. PubMed ID: 23602254
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2.
Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y
Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277
[TBL] [Abstract][Full Text] [Related]
40. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
